Evidence map›Paper›PMID 25631046›Full record

ArticleThe Journal of biological chemistry2015

Nedd4 family interacting protein 1 (Ndfip1) is required for ubiquitination and nuclear trafficking of BRCA1-associated ATM activator 1 (BRAT1) during the DNA damage response.

Ley-Hian Low, Yuh-Lit Chow, Yijia Li, Choo-Peng Goh, Ulrich Putz, John Silke, Toru Ouchi, Jason Howitt, Seong-Seng Tan

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. BRAT1 - a new therapeutic target for glioblastoma.Cellular and molecular life sciences : CMLS · 2025
    Article
  3. Article
  4. Article
  5. Neuronal differentiation requires BRAT1 complex to remove REST from chromatin.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Novel Biallelic Variant in theFrontiers in genetics · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Engineered Exosomes as Vehicles for Biologically Active Proteins.Molecular therapy : the journal of the American Society of Gene Therapy · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Ley-Hian LowFrom the Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, 3010 Victoria, Australia.
Yuh-Lit ChowFrom the Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, 3010 Victoria, Australia.
Yijia LiFrom the Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, 3010 Victoria, Australia.
Choo-Peng GohFrom the Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, 3010 Victoria, Australia.
Ulrich PutzFrom the Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, 3010 Victoria, Australia.
John Silkethe Walter & Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Parkville, 3010 Victoria, Australia, and.
Toru Ouchithe Department of Cancer Genetics, Roswell Park Cancer Institute, Elm & Carlton Streets, Buffalo, New York 14263.
Jason HowittFrom the Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, 3010 Victoria, Australia, jhowitt@florey.edu.au.
Seong-Seng TanFrom the Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, 3010 Victoria, Australia, stan@florey.edu.au.
Cancer Genetics (United States) · USWalter and Eliza Hall Institute of Medical Research · AU

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI MARK G FRATTINI · 1985 to 2026
$116.6M
NCI NIH HHS P30 CA016056
6 · The paper itself

Abstract

During injury, cells are vulnerable to apoptosis from a variety of stress conditions including DNA damage causing double-stranded breaks. Without repair, these breaks lead to aberrations in DNA replication and transcription, leading to apoptosis. A major response to DNA damage is provided by the protein kinase ATM (ataxia telangiectasia mutated) that is capable of commanding a plethora of signaling networks for DNA repair, cell cycle arrest, and even apoptosis. A key element in the DNA damage response is the mobilization of activating proteins into the cell nucleus to repair damaged DNA. BRAT1 is one of these proteins, and it functions as an activator of ATM by maintaining its phosphorylated status while also keeping other phosphatases at bay. However, it is unknown how BRAT1 is trafficked into the cell nucleus to maintain ATM phosphorylation. Here we demonstrate that Ndfip1-mediated ubiquitination of BRAT1 leads to BRAT1 trafficking into the cell nucleus. Without Ndfip1, BRAT1 failed to translocate to the nucleus. Under genotoxic stress, cells showed increased expression of both Ndfip1 and phosphorylated ATM. Following brain injury, neurons show increased expression of Ndfip1 and nuclear translocation of BRAT1. These results point to Ndfip1 as a sensor protein during cell injury and Ndfip1 up-regulation as a cue for BRAT1 ubiquitination by Nedd4 E3 ligases, followed by nuclear translocation of BRAT1.

Indexed as

Active Transport, Cell NucleusAnimalsAtaxia Telangiectasia Mutated ProteinsBrain InjuriesCarrier ProteinsCell LineDNA DamageEndosomal Sorting Complexes Required for TransportHEK293 CellsHumansIntercellular Signaling Peptides and ProteinsMembrane ProteinsMice, Inbred C57BLNedd4 Ubiquitin Protein LigasesNuclear ProteinsProtein BindingAtaxia Telangiectasia Mutated ProteinsBRAT1 protein, humanBRAT1 protein, mouseCarrier ProteinsEndosomal Sorting Complexes Required for TransportIntercellular Signaling Peptides and ProteinsMembrane ProteinsNDFIP1 protein, humanNdfip1 protein, mouseNedd4l protein, mouseNedd4 protein, humanNedd4 Ubiquitin Protein LigasesNuclear ProteinsUbiquitin-Protein LigasesDNA Damage ResponseIntracellular TraffickingNeuroprotectionNuclear TransportUbiquitylation (ubiquitination)

Identifiers

PMID25631046
PMCPMC4358134
OpenAlexW2068603497

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.